×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: COVID-19 vaccine from GSK and Vir

GSK-Vir COVID-19 Antibody Muscle Injection as Effective as Intravenous Shot

GSK COVID-19 vaccine
(AP)

Friday, 12 November 2021 07:49 AM EST

Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 therapy met the primary goal of a late-state study assessing intramuscular administration of the drug as a treatment for the illness in its early stages.

The study showed the treatment, sotrovimab, when injected into the muscle was as good as when given intravenously for early treatment of mild-to-moderate COVID-19 in high-risk, non-hospitalized adults and adolescents.

The results open up possibilities for making the treatment available more widely.

© 2023 Thomson/Reuters. All rights reserved.


StreetTalk
Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 therapy met the primary goal of a late-state study assessing intramuscular administration of the drug as a treatment for the illness in its early stages.The study showed the treatment, sotrovimab,...
COVID-19 vaccine from GSK and Vir
78
2021-49-12
Friday, 12 November 2021 07:49 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Get Newsmax Text Alerts
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved